Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000094544

Apexbio Technology LLC Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Tigatuzumab) 1mg
SDP

Supplier:  Apexbio Technology LLC F10441

Encompass

Tigatuzumab (CAS 918127-53-4) is a recombinant human IgG1 monoclonal antibody targeting tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) also known as TRAIL receptor 2 (TRAILR2) or CD262 It is designed to bind DR5 a receptor expressed on the surface of diverse cancer cells thereby modulating apoptosis-associated signaling pathways Tigatuzumab exerts its biological activity primarily through induction of apoptosis via receptor-mediated caspase-dependent mechanisms leading to tumor cell death and inhibition of tumor growth Based on these pharmacological properties tigatuzumab holds research potential in oncology and apoptosis-associated signaling pathway studies both in vitro and in vivo

Catalog No. 50-000-94544


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.